Invention Grant
- Patent Title: Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
-
Application No.: US16316688Application Date: 2017-07-07
-
Publication No.: US10906888B2Publication Date: 2021-02-02
- Inventor: Agustin Casimiro-Garcia , Joseph Walter Strohbach , David Hepworth , Frank Eldridge Lovering , Chulho Choi , Christophe Philippe Allais , Stephen Wayne Wright
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent James T. Wasicak
- International Application: PCT/IB2017/054104 WO 20170707
- International Announcement: WO2018/011681 WO 20180118
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D403/14 ; C07D413/14 ; C07D471/08 ; C07D487/04 ; C07D487/10 ; C07D491/107 ; C07D498/10 ; C07D498/18
Abstract:
Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Public/Granted literature
- US20190315715A1 NOVEL PYRIMIDINE CARBOXAMIDES AS INHIBITORS OF VANIN-1 ENZYME Public/Granted day:2019-10-17
Information query
